Abstract
Tuberculosis is a high-impact disease, diagnosed in 10.6 million patients and with a fatality rate of 1.3 million people in 2022 alone. The main drugs used to combat the disease are: isoniazid, rifampicin, ethambutol and pyrazinamide. Various studies have been carried out to understand the mechanism of action of these drugs, but there is no consensus on pyrazinamide (PZA). Two hypotheses …